Drugs / PBR28
PBR28
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00407693 | Nov 2006 → Jul 2016 | — | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
| Phase 1 | NCT00283920 | Jan 2006 → Oct 2007 | — | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBR28 | “PBR28 is distributed in the body of healthy volunteers” NCT00407693 ↗ |
| Known as | [(11)C] PBR28 | “Recently we developed a new ligand, N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine \[(11)C\]PBR28, which showed much greater specific signals than \[(11)C\]PK11195 in...” NCT00283920 ↗ |
| Known as | N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine | “Recently we developed a new ligand, N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine \[(11)C\]PBR28, which showed much greater specific signals than \[(11)C\]PK11195 in...” NCT00283920 ↗ |
| Modality | Diagnostic / imaging agent | “Therefore, \[(11)C\]PBR28 is a promising PET ligand.” NCT00407693 ↗ |
| Route | Intravenous | “After the tracer is injected through a catheter (plastic tube) placed in the arm, pictures are taken for 2 to 3 hours” NCT00283920 ↗ |